company background image
MEGA

Mega Lifesciences SET:MEGA Stock Report

Last Price

฿46.25

Market Cap

฿40.3b

7D

5.1%

1Y

-2.1%

Updated

25 Sep, 2023

Data

Company Financials +

Mega Lifesciences Public Company Limited

SET:MEGA Stock Report

Mkt Cap: ฿40.3b

MEGA Stock Overview

Mega Lifesciences Public Company Limited, together with its subsidiaries, manufactures and sells health food supplements, prescription pharmaceutical products, over-the-counter (OTC) products, herbal products, vitamins, and fast moving consumer goods.

MEGA fundamental analysis
Snowflake Score
Valuation3/6
Future Growth2/6
Past Performance3/6
Financial Health6/6
Dividends4/6

Mega Lifesciences Public Company Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Mega Lifesciences
Historical stock prices
Current Share Price฿46.25
52 Week High฿52.50
52 Week Low฿34.75
Beta0.47
1 Month Change9.47%
3 Month Change27.59%
1 Year Change-2.12%
3 Year Change27.59%
5 Year Change20.13%
Change since IPO117.14%

Recent News & Updates

Recent updates

Shareholder Returns

MEGATH PharmaceuticalsTH Market
7D5.1%-1.9%-1.2%
1Y-2.1%12.0%-6.7%

Return vs Industry: MEGA underperformed the TH Pharmaceuticals industry which returned 12% over the past year.

Return vs Market: MEGA exceeded the TH Market which returned -6.7% over the past year.

Price Volatility

Is MEGA's price volatile compared to industry and market?
MEGA volatility
MEGA Average Weekly Movement3.4%
Pharmaceuticals Industry Average Movement4.7%
Market Average Movement4.3%
10% most volatile stocks in TH Market8.6%
10% least volatile stocks in TH Market2.2%

Stable Share Price: MEGA is not significantly more volatile than the rest of TH stocks over the past 3 months, typically moving +/- 3% a week.

Volatility Over Time: MEGA's weekly volatility (3%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1982n/aVivek Dhawanhttps://www.megawecare.com

Mega Lifesciences Public Company Limited, together with its subsidiaries, manufactures and sells health food supplements, prescription pharmaceutical products, over-the-counter (OTC) products, herbal products, vitamins, and fast moving consumer goods. The company operates through three segments: Brands, Distribution, and Original Equipment Manufacture. It provides various medicines for allergy, blood circulation and memory, bone and joint, kids, liver and digestive, eye, heart, pain, skin, sleeping, well-being, herbal, and cough and cold care, as well as vitamins, probiotics, medical and sports nutrition, and men’s and women’s care products; and prescription medicines in the areas of anti-allergic, anti-infective, central nervous system, cardio vascular system, dermatology, diabetes, gastroenterology, gynaecology, nephrology, oncology, ophthalmology, orthopaedic, pain, respiratory, rheumatology, and urology.

Mega Lifesciences Public Company Limited Fundamentals Summary

How do Mega Lifesciences's earnings and revenue compare to its market cap?
MEGA fundamental statistics
Market Cap฿40.32b
Earnings (TTM)฿2.04b
Revenue (TTM)฿15.69b

19.7x

P/E Ratio

2.6x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
MEGA income statement (TTM)
Revenue฿15.69b
Cost of Revenue฿8.55b
Gross Profit฿7.14b
Other Expenses฿5.10b
Earnings฿2.04b

Last Reported Earnings

Jun 30, 2023

Next Earnings Date

Nov 14, 2023

Earnings per share (EPS)2.34
Gross Margin45.51%
Net Profit Margin13.01%
Debt/Equity Ratio3.0%

How did MEGA perform over the long term?

See historical performance and comparison

Dividends

3.6%

Current Dividend Yield

70%

Payout Ratio